Mohammed Ahmed Abdullah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohammed Ahmed Abdullah has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Salwa A. Musa
Department of Pediatrics and Child Health, Faculty of Medicine, Al-Neelain University, Khartoum
5 shared publications - Ghassan Faisal Fadlalbari
Department of Pediatric Medicine, Division of Endocrine , Sidra Hospital , Doha , Qatar
4 shared publications - Samar Abu Samra
Department of Pediatrics Endocrinology and Diabetes, Gaafar Ibn Auf Pediatric Tertiary Hospital, Khartoum
4 shared publications - Abeer Alassaf
Department of Pediatrics , University of Jordan , Amman , Jordan
3 shared publications - Areej Ahmed Bashier Ibrahim
Department of Pediatrics, Division of Pediatric Endocrine , Prince Mohammed Bin Abdulaziz Hospital , Madinah , Saudi Arabia
3 shared publications - Bashir Mukhtar Elwasila Elmahi
Department of Paediatrics and Child Health, University of Khartoum, Faculty of Medicine, Khartoum, Sudan
3 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Knowledge E DMCC in Sudan Journal of Medical Sciences
- Vol. 21 (2) , 334-341
Absence of Tears as a Key Clinical Clue to Triple A Syndrome: A Case Report
Background: Triple A syndrome (TAS), also referred to as Allgrove Syndrome (AS), is a rare inherited multisystem disorder. Mutations in the AAAS gene, which encodes the nuclear pore complex protein ALADIN, are responsible for this syndrome, named for its main features of (ALacrima, Achalasia, ADrenal Insufficiency, and Neurological disorder). Absence of tears (alacrima), the earliest clinical manifestation of this syndrome, is frequently overlooked, leading to significant delays in clinical recognition. Case Report: We report a young female child who presented late with features suggestive of severe adrenal crisis secondary to primary adrenal insufficiency (PAI). She was born to first-degree relatives who had three deceased siblings with similar presentations, all of whom presumably died from untreated adrenal crises. Alacrima had been present in all siblings since birth and served as the key diagnostic clue in this case, enabling early recognition and appropriate life-saving intervention. The clinical presentation of TAS is highly heterogeneous, and early signs are nonspecific, which often contributes to diagnostic uncertainty and delays or missed diagnoses. In a country with limited resources for specific testing and inaccessible genetic diagnosis, such as Sudan, diagnosis relies primarily on careful clinical evaluation to identify key phenotypic features that eventually lead to accurate and timely diagnosis and management. Conclusion: This case report underscores the importance of clinical awareness in the identification and timely management of TAS. It also highlights the critical role of careful clinical evaluation, particularly in children presenting with absence of tears, hyperpigmentation, and recurrent hypoglycemia, to facilitate early identification of cases and prevent life-threatening outcomes.
- 30 June 2026
- Published by Knowledge E DMCC in Sudan Journal of Medical Sciences
- Vol. 21 (2) , 334-341
Open AccessAbsence of Tears as a Key Clinical Clue to Triple A Syndrome: A Case Report
Background: Triple A syndrome (TAS), also referred to as Allgrove Syndrome (AS), is a rare inherited multisystem disorder. Mutations in the AAAS gene, which encodes the nuclear pore complex protein ALADIN, are responsible for this syndrome, named for its main features of (ALacrima, Achalasia, ADrenal Insufficiency, and Neurological disorder). Absence of tears (alacrima), the earliest clinical manifestation of this syndrome, is frequently overlooked, leading to significant delays in clinical recognition. Case Report: We report a young female child who presented late with features suggestive of severe adrenal crisis secondary to primary adrenal insufficiency (PAI). She was born to first-degree relatives who had three deceased siblings with similar presentations, all of whom presumably died from untreated adrenal crises. Alacrima had been present in all siblings since birth and served as the key diagnostic clue in this case, enabling early recognition and appropriate life-saving intervention. The clinical presentation of TAS is highly heterogeneous, and early signs are nonspecific, which often contributes to diagnostic uncertainty and delays or missed diagnoses. In a country with limited resources for specific testing and inaccessible genetic diagnosis, such as Sudan, diagnosis relies primarily on careful clinical evaluation to identify key phenotypic features that eventually lead to accurate and timely diagnosis and management. Conclusion: This case report underscores the importance of clinical awareness in the identification and timely management of TAS. It also highlights the critical role of careful clinical evaluation, particularly in children presenting with absence of tears, hyperpigmentation, and recurrent hypoglycemia, to facilitate early identification of cases and prevent life-threatening outcomes.
- Open Access
- 9 April 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200634
Cardiovascular disease burden in children with obesity: A narrative review
- 9 April 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200634
Open AccessCardiovascular disease burden in children with obesity: A narrative review
- Open Access
- 30 December 2025
- Published by Springer Nature in Research Square
Linguistic, Ethnicity, and Geographical distribution of type 1 diabetes mellitus in Sudanese patients
The pattern of linguistic, ethnic, and geographical distribution of type 1 diabetes mellitus (T1D) among Sudanese patients is not well recognized. To determine this disturbuation, 50 T1D patients from diverse Sudanese ethnic groups who reported to Sudan Childhood Diabetes Center in Khartoum and two groups of controls, 118 genome data with other complaints, microarray data of 221 healthy controls of the Sudanese national genome (SNGP), were enrolled. In order to compare and examine how the disease is distributed among Sudanese tribes. It was found that the majority of patients with T1D were Arabs (82% Gaalien 26%, Shaigia 8%, Messiria 8%, Hammar 8%, Rufa'a 26%, Rawashda and Rekabia 4%), 2% were Hausa and 2% were Falata. 14% of the population was Nubian (4% Halfawi, 4% Mahas and 6% Danagla). The distribution was 78% for Afro-Asiatic (AA), 20% for Nilo-Saharan (NS) and 2% Niger-Kordofanian (NK), based on language groups. Geographically, the data showed that 52% of cases originated in North Sudan, 22% in the West, 24% in the Center, and 2% of the entire research group in East Sudan. Significant variation was found between the linguistic groups (AA and NS + NK) of T1D patients (p < 0.0001). There was a significant difference between the prevalence of language groups in the T1D group and the 118 control group (P < 0.002824). When comparing SNGP data and T1D data, a pattern of linguistic and geographical distribution of Sudanese tribes was statistically significant (P < 0.0001). It was found that 18 variants were shared with the T1D data. According to minor allele frequency (MAF), some variants were rare in some populations while they were common in other populations. Seven variants were classified as common variants in all linguistic groups based on MAF > 0.05. Eight variants were rare in some language groups (MAF < 0.05), but rare in others. Based on their clinical significance, the “benign” category included 13 variants (72.2%). 4 (22.2%) variants were classified as probably benign; only one variant (rs147638455) was found to have conflicting pathogenicity in all populations. Arabs make up an estimated number in Sudan, while the majority are Africans. Nevertheless, the majority of the population with T1D consists of Arabs, where they lived in central and then in northern Sudan. It is therefore extremely unlikely that changes in the genetic background are responsible for the observed regional differences against this background. Minor alleles are more likely to be risk alleles, particularly for some diseases where minor allele frequency (MAF) is low. Due to the complicated ethnic composition of the Sudanese population, there can be significant fluctuations. In conclusion, in this study, it was very clear that there is a pattern of spread of the disease among the Arab population or among people of Arab descent, most of whom return to the Arabian Peninsula. The highest rates of T1D are in Nordic countries and in high-income Arab countries. This could explain some issues related to the degree of closeness between these populations and the Sudanese tribes. Future research to estimate the extent of negative natural selection in various complicated disorders may use these findings as a starting point.
- 30 December 2025
- Published by Springer Nature in Research Square
Open AccessLinguistic, Ethnicity, and Geographical distribution of type 1 diabetes mellitus in Sudanese patients
The pattern of linguistic, ethnic, and geographical distribution of type 1 diabetes mellitus (T1D) among Sudanese patients is not well recognized. To determine this disturbuation, 50 T1D patients from diverse Sudanese ethnic groups who reported to Sudan Childhood Diabetes Center in Khartoum and two groups of controls, 118 genome data with other complaints, microarray data of 221 healthy controls of the Sudanese national genome (SNGP), were enrolled. In order to compare and examine how the disease is distributed among Sudanese tribes. It was found that the majority of patients with T1D were Arabs (82% Gaalien 26%, Shaigia 8%, Messiria 8%, Hammar 8%, Rufa'a 26%, Rawashda and Rekabia 4%), 2% were Hausa and 2% were Falata. 14% of the population was Nubian (4% Halfawi, 4% Mahas and 6% Danagla). The distribution was 78% for Afro-Asiatic (AA), 20% for Nilo-Saharan (NS) and 2% Niger-Kordofanian (NK), based on language groups. Geographically, the data showed that 52% of cases originated in North Sudan, 22% in the West, 24% in the Center, and 2% of the entire research group in East Sudan. Significant variation was found between the linguistic groups (AA and NS + NK) of T1D patients (p < 0.0001). There was a significant difference between the prevalence of language groups in the T1D group and the 118 control group (P < 0.002824). When comparing SNGP data and T1D data, a pattern of linguistic and geographical distribution of Sudanese tribes was statistically significant (P < 0.0001). It was found that 18 variants were shared with the T1D data. According to minor allele frequency (MAF), some variants were rare in some populations while they were common in other populations. Seven variants were classified as common variants in all linguistic groups based on MAF > 0.05. Eight variants were rare in some language groups (MAF < 0.05), but rare in others. Based on their clinical significance, the “benign” category included 13 variants (72.2%). 4 (22.2%) variants were classified as probably benign; only one variant (rs147638455) was found to have conflicting pathogenicity in all populations. Arabs make up an estimated number in Sudan, while the majority are Africans. Nevertheless, the majority of the population with T1D consists of Arabs, where they lived in central and then in northern Sudan. It is therefore extremely unlikely that changes in the genetic background are responsible for the observed regional differences against this background. Minor alleles are more likely to be risk alleles, particularly for some diseases where minor allele frequency (MAF) is low. Due to the complicated ethnic composition of the Sudanese population, there can be significant fluctuations. In conclusion, in this study, it was very clear that there is a pattern of spread of the disease among the Arab population or among people of Arab descent, most of whom return to the Arabian Peninsula. The highest rates of T1D are in Nordic countries and in high-income Arab countries. This could explain some issues related to the degree of closeness between these populations and the Sudanese tribes. Future research to estimate the extent of negative natural selection in various complicated disorders may use these findings as a starting point.
- 10 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (1) , 65-75
Characterization of monogenic diabetes among Sudanese children: a multi-center experience from a population with high consanguinity
Objectives: Monogenic diabetes (MD) is a group of diabetes subtypes caused by defects in single genes. We report phenotypes and genotypes of MD among Sudanese children. Methods: Referred patients (from birth to 18 years of age) with diabetes and a clinical diagnosis of MD to Gaafar Ibnauf Pediatric Tertiary Hospital or the Sudan Childhood Diabetes Center between January 2006 and April 2023 were included. Patients were divided into two groups based on onset of diabetes before six months of age (Group 1, or neonatal diabetes mellitus) or after (Group 2, or non-neonatal diabetes mellitus). Genetic testing was performed for 87 patients at the Exeter Genomics laboratory and for one patient at the University of Cambridge, Metabolic Research Laboratories, UK. Results: Out of 88 patients, 50 were from Group 1 and 38 from Group 2. We reported consanguinity in 63.6 % of the cohort and identified disease-causing variants for 18 genes in 43.2 % (Group 1) and 37.5 % (Group 2) of patients from the total cohort. The commonest causes in Group 1 and Group 2 were pathogenic variants in the EIF2AK3 and WFS1 genes, respectively. Pathogenic variants in recently reported novel genes ZNF808 , NARS2 , and FICD were detected in 8.5 %, 4.2%, and 1.4 % of patients, respectively. Patients with a disrupted WFS1 gene were found to have deafness (92.8 %) and optic atrophy (64 %). While skeletal deformities and liver disease were both seen in 28.6 % of patients with pathogenic variants in the ElF2AK3 gene. Hepatomegaly and hypophosphatemic rickets were uniformly seen in patients with pathogenic variants in the SLC2A2 gene. Generalized subcutaneous tissue loss and acanthosis nigricans were main features in AGPAT2 and INSR variants, respectively. Conclusions: Characterization of MD in Sudan showed a predominance of syndromic forms. Genetic studies conducted on consanguineous populations may raise higher probabilities in identifying rare genes.
- 10 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (1) , 65-75
Characterization of monogenic diabetes among Sudanese children: a multi-center experience from a population with high consanguinity
Objectives: Monogenic diabetes (MD) is a group of diabetes subtypes caused by defects in single genes. We report phenotypes and genotypes of MD among Sudanese children. Methods: Referred patients (from birth to 18 years of age) with diabetes and a clinical diagnosis of MD to Gaafar Ibnauf Pediatric Tertiary Hospital or the Sudan Childhood Diabetes Center between January 2006 and April 2023 were included. Patients were divided into two groups based on onset of diabetes before six months of age (Group 1, or neonatal diabetes mellitus) or after (Group 2, or non-neonatal diabetes mellitus). Genetic testing was performed for 87 patients at the Exeter Genomics laboratory and for one patient at the University of Cambridge, Metabolic Research Laboratories, UK. Results: Out of 88 patients, 50 were from Group 1 and 38 from Group 2. We reported consanguinity in 63.6 % of the cohort and identified disease-causing variants for 18 genes in 43.2 % (Group 1) and 37.5 % (Group 2) of patients from the total cohort. The commonest causes in Group 1 and Group 2 were pathogenic variants in the EIF2AK3 and WFS1 genes, respectively. Pathogenic variants in recently reported novel genes ZNF808 , NARS2 , and FICD were detected in 8.5 %, 4.2%, and 1.4 % of patients, respectively. Patients with a disrupted WFS1 gene were found to have deafness (92.8 %) and optic atrophy (64 %). While skeletal deformities and liver disease were both seen in 28.6 % of patients with pathogenic variants in the ElF2AK3 gene. Hepatomegaly and hypophosphatemic rickets were uniformly seen in patients with pathogenic variants in the SLC2A2 gene. Generalized subcutaneous tissue loss and acanthosis nigricans were main features in AGPAT2 and INSR variants, respectively. Conclusions: Characterization of MD in Sudan showed a predominance of syndromic forms. Genetic studies conducted on consanguineous populations may raise higher probabilities in identifying rare genes.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Exome Sequencing of a Type 1 Diabetes Mellitus Family Exposes Both Common and Individualized Rare Variants Contributing to Pathogenesis
Type 1 diabetes mellitus (T1D) is a disease of complex inheritance where genetic, immunological, and environmental factors interact in rendering the ultimate phenotype. To gain insights into the molecular etiology of the disease in a subset of a population that is sparsely investigated in genetic terms, like in Africa, exome sequence data from a T1D multicase family and a T1D cohort were investigated. The exome analysis identified several candidate genes related to T1D, like human leukocyte antigen (HLA), insulin (INS) gene, Cytotoxic T‐lymphocyte–Associated Protein 4 (CTLA4), Protein Tyrosine Phosphatase Nonreceptor Type 22 (PTPN22), and Interferon‐Induced Helicase C Domain 1 (IFIH1). A total of eight pathways were significantly overrepresented ( p value ≤ 0.05) in target lists analyzed, including WNT, MARS2, TARS, STK36, TYR, TP73, ATIC, and HNF4. Based on Condel functionality scores and centrality positions in genetic interaction networks, two prominent candidates in diabetes mellitus and maturity‐onset diabetes of the young (MODY)—HNF1A rs2464195 and HNF4A rs147638455—were identified. The two candidate variants were subsequently genotyped for further replication in a total of 47 T1D cases and 20 unrelated controls. No significant differences were observed ( p = 0.73 and p = 1), as the variants turned out to be relatively common among Sudanese and absent or rare in a global sample. Expression analysis of these loci was carried out alongside two miRNAs, miR‐105 and miR‐518, which were selected based on in silico prediction ( p = 0.057 and 0.038, respectively). The results revealed profound miRNA differential expression between T1D cases and controls, suggesting a role for miRNA in the regulation of susceptibility networks, but also the existence of within‐family differences in the fold change. Such differences, especially if taken in connection with the clinical differences encountered in this family and the population variation, highlight the potential of both population‐based and individualized approaches in fathoming underlying causes of pathogenesis leading to a T1D phenotype.
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Open AccessExome Sequencing of a Type 1 Diabetes Mellitus Family Exposes Both Common and Individualized Rare Variants Contributing to Pathogenesis
Type 1 diabetes mellitus (T1D) is a disease of complex inheritance where genetic, immunological, and environmental factors interact in rendering the ultimate phenotype. To gain insights into the molecular etiology of the disease in a subset of a population that is sparsely investigated in genetic terms, like in Africa, exome sequence data from a T1D multicase family and a T1D cohort were investigated. The exome analysis identified several candidate genes related to T1D, like human leukocyte antigen (HLA), insulin (INS) gene, Cytotoxic T‐lymphocyte–Associated Protein 4 (CTLA4), Protein Tyrosine Phosphatase Nonreceptor Type 22 (PTPN22), and Interferon‐Induced Helicase C Domain 1 (IFIH1). A total of eight pathways were significantly overrepresented ( p value ≤ 0.05) in target lists analyzed, including WNT, MARS2, TARS, STK36, TYR, TP73, ATIC, and HNF4. Based on Condel functionality scores and centrality positions in genetic interaction networks, two prominent candidates in diabetes mellitus and maturity‐onset diabetes of the young (MODY)—HNF1A rs2464195 and HNF4A rs147638455—were identified. The two candidate variants were subsequently genotyped for further replication in a total of 47 T1D cases and 20 unrelated controls. No significant differences were observed ( p = 0.73 and p = 1), as the variants turned out to be relatively common among Sudanese and absent or rare in a global sample. Expression analysis of these loci was carried out alongside two miRNAs, miR‐105 and miR‐518, which were selected based on in silico prediction ( p = 0.057 and 0.038, respectively). The results revealed profound miRNA differential expression between T1D cases and controls, suggesting a role for miRNA in the regulation of susceptibility networks, but also the existence of within‐family differences in the fold change. Such differences, especially if taken in connection with the clinical differences encountered in this family and the population variation, highlight the potential of both population‐based and individualized approaches in fathoming underlying causes of pathogenesis leading to a T1D phenotype.
- Open Access
- 1 January 2025
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1)
Mauriac Syndrome in Sudanese Children: An Old Syndrome Still Existing in Resource‐Limited Countries
Objective: Mauriac syndrome (MS) is a rare condition linked to inadequate glycemic control in type 1 diabetes mellitus (T1DM) and has also rarely been reported in patients with neonatal diabetes. MS manifests as growth failure, delayed puberty, cushingoid features, and hepatomegaly. The condition can be associated with complications like dyslipidemia, retinopathy, and nephropathy. The main objective of this study was to describe the magnitude of the condition, clinical features, management, and outcome of Sudanese children and adolescents with MS due to inadequate control of diabetes in our center. Study Design and Methods: This is a cross‐sectional hospital‐based study. All medical records of patients with MS were reviewed. Data, including demographics, clinical features, investigations, management, and outcome, were obtained. Patients were re‐educated and management intensified then followed up. Results: Thirty‐seven MS patients were enrolled in this study, with a male predominance of 59.5%. Neonatal diabetes was diagnosed in 5.4% of the patients, while others had T1DM. The median age at diagnosis of MS was 12 years. The diagnosis was based solely on clinical findings, including a history of prolonged unsatisfactory glycemic control, short stature, and hepatomegaly. Regarding the outcome, eight children (21.6%) were lost to follow‐up, one patient died (2.7%), seven (18.9%) had a static condition, and those who showed improvement were 21 (56.8%). Signs of improvement were a decrease in liver size with or without an increase in growth velocity. Nephropathy was the most common associated complication; it was seen in 33.3% of our cohort. Some got it at a very young age. Conclusions: Despite many efforts that have been made to achieve better glycemic control in children with T1DM, MS still exists in our setting. Though liver biopsy is the gold standard for diagnosis, being invasive, the diagnosis could be made conservatively, based on clinical features and response to treatment. The condition can be reversed with good metabolic control.
- 1 January 2025
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1)
Open AccessMauriac Syndrome in Sudanese Children: An Old Syndrome Still Existing in Resource‐Limited Countries
Objective: Mauriac syndrome (MS) is a rare condition linked to inadequate glycemic control in type 1 diabetes mellitus (T1DM) and has also rarely been reported in patients with neonatal diabetes. MS manifests as growth failure, delayed puberty, cushingoid features, and hepatomegaly. The condition can be associated with complications like dyslipidemia, retinopathy, and nephropathy. The main objective of this study was to describe the magnitude of the condition, clinical features, management, and outcome of Sudanese children and adolescents with MS due to inadequate control of diabetes in our center. Study Design and Methods: This is a cross‐sectional hospital‐based study. All medical records of patients with MS were reviewed. Data, including demographics, clinical features, investigations, management, and outcome, were obtained. Patients were re‐educated and management intensified then followed up. Results: Thirty‐seven MS patients were enrolled in this study, with a male predominance of 59.5%. Neonatal diabetes was diagnosed in 5.4% of the patients, while others had T1DM. The median age at diagnosis of MS was 12 years. The diagnosis was based solely on clinical findings, including a history of prolonged unsatisfactory glycemic control, short stature, and hepatomegaly. Regarding the outcome, eight children (21.6%) were lost to follow‐up, one patient died (2.7%), seven (18.9%) had a static condition, and those who showed improvement were 21 (56.8%). Signs of improvement were a decrease in liver size with or without an increase in growth velocity. Nephropathy was the most common associated complication; it was seen in 33.3% of our cohort. Some got it at a very young age. Conclusions: Despite many efforts that have been made to achieve better glycemic control in children with T1DM, MS still exists in our setting. Though liver biopsy is the gold standard for diagnosis, being invasive, the diagnosis could be made conservatively, based on clinical features and response to treatment. The condition can be reversed with good metabolic control.
- Open Access
- 15 February 2024
- Published by Wiley in Pediatric Diabetes
- Vol. 2024, 1-10
Incidence, Phenotypes, and Genotypes of Neonatal Diabetes: A 16-Year Experience. The Rare Genetic Etiologies of Neonatal Diabetes Are Common in Sudan
Neonatal diabetes (ND) is a rare subtype of diabetes occurring in the first 6months of life. High incidence has been reported among populations with high rates of consanguineous marriage. However, there is paucity of reported data from sub-Saharan African countries. We report the incidence, genotype, and phenotype of ND in a large cohort from Sudan and compare these findings to regional and international data. All infants with onset of diabetes in the first 6months of life, attending one of the only two tertiary pediatric diabetes centers in Sudan, Gaafar Ibn Auf Pediatric Tertiary Hospital and Sudan Childhood Diabetes Center, during the period of January 2006 to December 2022 were included. Medical records were reviewed for demographic and clinical information. Genetic testing was performed for 48 patients by the Exeter Genomics laboratory in the UK and for one patient by the University of Cambridge, Metabolic Research Laboratories, UK. The estimated incidence was 4.8 per 100,000 live births. Forty-nine ND patients from 45 unrelated families were identified, and a genetic diagnosis was confirmed in 37 patients (75.5) from 33 unrelated families. Consanguinity was reported in 34 families (75.6). The commonest genetic cause for permanent neonatal diabetes was EIF2AK3 recessive variants causing WolcottRallison syndrome (18.92). Pathogenic variants in two recently identified genes, ZNF808 and NARS2, were found in three patients each (8.11). Activating variants in KCNJ11 and ABCC8 were identified in four (10.81) and two (5.41) patients, respectively. Apart from hyperglycemia, the commonest clinical presentations included dehydration, failure to thrive, and diabetic ketoacidosis. ND in Sudan has a different pattern of etiologies compared to Western and Asian populations yet similar to some Arab countries with EIF2AK3 mutations being the commonest cause. Pathogenic variants in recently identified genes reflect the impact of genome sequencing on increasing the rate of genetic diagnosis.
- 15 February 2024
- Published by Wiley in Pediatric Diabetes
- Vol. 2024, 1-10
Open AccessIncidence, Phenotypes, and Genotypes of Neonatal Diabetes: A 16-Year Experience. The Rare Genetic Etiologies of Neonatal Diabetes Are Common in Sudan
Neonatal diabetes (ND) is a rare subtype of diabetes occurring in the first 6months of life. High incidence has been reported among populations with high rates of consanguineous marriage. However, there is paucity of reported data from sub-Saharan African countries. We report the incidence, genotype, and phenotype of ND in a large cohort from Sudan and compare these findings to regional and international data. All infants with onset of diabetes in the first 6months of life, attending one of the only two tertiary pediatric diabetes centers in Sudan, Gaafar Ibn Auf Pediatric Tertiary Hospital and Sudan Childhood Diabetes Center, during the period of January 2006 to December 2022 were included. Medical records were reviewed for demographic and clinical information. Genetic testing was performed for 48 patients by the Exeter Genomics laboratory in the UK and for one patient by the University of Cambridge, Metabolic Research Laboratories, UK. The estimated incidence was 4.8 per 100,000 live births. Forty-nine ND patients from 45 unrelated families were identified, and a genetic diagnosis was confirmed in 37 patients (75.5) from 33 unrelated families. Consanguinity was reported in 34 families (75.6). The commonest genetic cause for permanent neonatal diabetes was EIF2AK3 recessive variants causing WolcottRallison syndrome (18.92). Pathogenic variants in two recently identified genes, ZNF808 and NARS2, were found in three patients each (8.11). Activating variants in KCNJ11 and ABCC8 were identified in four (10.81) and two (5.41) patients, respectively. Apart from hyperglycemia, the commonest clinical presentations included dehydration, failure to thrive, and diabetic ketoacidosis. ND in Sudan has a different pattern of etiologies compared to Western and Asian populations yet similar to some Arab countries with EIF2AK3 mutations being the commonest cause. Pathogenic variants in recently identified genes reflect the impact of genome sequencing on increasing the rate of genetic diagnosis.
- 30 May 2022
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (7) , 938-945
Clinical profile and aetiologies of delayed puberty: a 15 years’ experience from a tertiary centre in Sudan
Objectives: Delayed puberty is a common presentation to endocrine clinics, with adult height, sexual capability and fertility being the main concerns for the child and his/her family. Presentation is variable including short stature and/or absence of secondary sexual characteristics. The aetiology can either be constitutional, functional or permanent hypogonadotropic hypogonadism, permanent hypergonadotropic hypogonadism or unclassified. Despite the importance of this subject, there are no publications from Sudan. Methods: A retrospective hospital-based study. Records of all patients who were seen in the endocrinology unit at Gaffar Ibn Auf Children’s Hospital and were diagnosed as having delayed puberty were reviewed and demographic, clinical, and investigations data were obtained. Results: A total of 136 patients were included in this study. Presentation includes short stature in 52.2%, both short stature and delayed puberty in 27.2%, and delayed puberty in 20.6%. The most common aetiologies were permanent hypogonadotropic hypogonadism and functional hypogonadotropic hypogonadism presented in 37.5% and 36% respectively, while constitutional delay of growth and puberty was found in only 14.7%. Type 1 diabetes mellitus (T1DM) was the most frequent chronic illness followed by coeliac disease. Hypergonadotropic hypogonadism was diagnosed in 11.7%, the majority of which were females. Conclusions: The aetiological pattern reported in this series highlights the role of nutrition and general well-being in pubertal development, as well as the major impact of genetics and consanguinity on disease patterns. Data from African countries are limited and this is the first reported cohort on delayed puberty from Sudan.
- 30 May 2022
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (7) , 938-945
Clinical profile and aetiologies of delayed puberty: a 15 years’ experience from a tertiary centre in Sudan
Objectives: Delayed puberty is a common presentation to endocrine clinics, with adult height, sexual capability and fertility being the main concerns for the child and his/her family. Presentation is variable including short stature and/or absence of secondary sexual characteristics. The aetiology can either be constitutional, functional or permanent hypogonadotropic hypogonadism, permanent hypergonadotropic hypogonadism or unclassified. Despite the importance of this subject, there are no publications from Sudan. Methods: A retrospective hospital-based study. Records of all patients who were seen in the endocrinology unit at Gaffar Ibn Auf Children’s Hospital and were diagnosed as having delayed puberty were reviewed and demographic, clinical, and investigations data were obtained. Results: A total of 136 patients were included in this study. Presentation includes short stature in 52.2%, both short stature and delayed puberty in 27.2%, and delayed puberty in 20.6%. The most common aetiologies were permanent hypogonadotropic hypogonadism and functional hypogonadotropic hypogonadism presented in 37.5% and 36% respectively, while constitutional delay of growth and puberty was found in only 14.7%. Type 1 diabetes mellitus (T1DM) was the most frequent chronic illness followed by coeliac disease. Hypergonadotropic hypogonadism was diagnosed in 11.7%, the majority of which were females. Conclusions: The aetiological pattern reported in this series highlights the role of nutrition and general well-being in pubertal development, as well as the major impact of genetics and consanguinity on disease patterns. Data from African countries are limited and this is the first reported cohort on delayed puberty from Sudan.
- Open Access
- 1 January 2022
- Published by Knowledge E DMCC in Dubai Diabetes and Endocrinology Journal
- Vol. 28 (4) , 143-146
Acute Lymphoblastic Leukemia in an Adolescent Girl with Graves’ Disease: A Coincidence or Consequence
Background: Graves’ disease (GD)-related bone marrow injury presents usually as agranulocytosis or less commonly as pancytopenia. However, acute lymphoblastic leukemia (ALL) has been reported recently in an adult patient with GD. The underlying pathogenesis is not fully understood. Nevertheless, the harmful effects of anti-thyroid drugs or autoimmune reaction to bone marrow cells are anticipated to be the causative factors. Case Presentation: We report a 16.5-year-old girl with GD who was on carbimazole for the first 14 months of her illness, with irregular follow-up; then it was withdrawn because she developed hypothyroidism. Meanwhile, she developed severe anemia without fever which necessitated blood transfusion. Eight months later, she presented with thyrotoxicosis relapse, febrile illness, bone pain, and pancytopenia which was proved to be ALL on bone marrow examination. Conclusion: The presence of ALL in a young GD patient is an unprecedented event. Although it is difficult to demonstrate the causality between them, need for further studies cannot be denied.
- 1 January 2022
- Published by Knowledge E DMCC in Dubai Diabetes and Endocrinology Journal
- Vol. 28 (4) , 143-146
Open AccessAcute Lymphoblastic Leukemia in an Adolescent Girl with Graves’ Disease: A Coincidence or Consequence
Background: Graves’ disease (GD)-related bone marrow injury presents usually as agranulocytosis or less commonly as pancytopenia. However, acute lymphoblastic leukemia (ALL) has been reported recently in an adult patient with GD. The underlying pathogenesis is not fully understood. Nevertheless, the harmful effects of anti-thyroid drugs or autoimmune reaction to bone marrow cells are anticipated to be the causative factors. Case Presentation: We report a 16.5-year-old girl with GD who was on carbimazole for the first 14 months of her illness, with irregular follow-up; then it was withdrawn because she developed hypothyroidism. Meanwhile, she developed severe anemia without fever which necessitated blood transfusion. Eight months later, she presented with thyrotoxicosis relapse, febrile illness, bone pain, and pancytopenia which was proved to be ALL on bone marrow examination. Conclusion: The presence of ALL in a young GD patient is an unprecedented event. Although it is difficult to demonstrate the causality between them, need for further studies cannot be denied.
- Open Access
- 21 December 2021
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 15 (1) , 1-5
Feminizing adrenocortical adenoma in a girl from a resource-limited setting: a case report
Background: An adrenocortical tumor is a rare tumor in pediatrics, which can be functional or nonfunctional. Functional tumors present with virilization, feminization, or hypercortisolism. Feminizing adrenal tumors, though rare in pediatrics, need to be excluded in any child presenting with features of feminization. Case presentation: We report a case of a 4-year-old Sudanese girl who presented with gradually progressive bilateral breast enlargement and accelerated growth since the age of 6 months. The family had sought medical advice several times in numerous health facilities without much gain. Investigations showed pubertal luteinizing hormone levels, high estradiol E2, and dehydroepiandrosterone sulfate, with normal early morning cortisol level. Abdominal ultrasound revealed a right-sided hypoechoic suprarenal mass. Abdominal computed tomography scan showed a right adrenal mass. The diagnosis of feminizing adrenal neoplasm was confirmed and right adrenalectomy was done. Histopathological examination of the resected adrenal gland showed adrenocortical adenoma. The patient was started on gonadotrophin-releasing hormone agonist for secondary central precocious puberty. Conclusion: Adrenocortical tumors, though rare in pediatrics, are a documented cause of precocious puberty; biochemical and imaging screening protocol should be adopted for patients with precocious puberty, even in a resource-limited setting, for early detection and treatment.
- 21 December 2021
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 15 (1) , 1-5
Open AccessFeminizing adrenocortical adenoma in a girl from a resource-limited setting: a case report
Background: An adrenocortical tumor is a rare tumor in pediatrics, which can be functional or nonfunctional. Functional tumors present with virilization, feminization, or hypercortisolism. Feminizing adrenal tumors, though rare in pediatrics, need to be excluded in any child presenting with features of feminization. Case presentation: We report a case of a 4-year-old Sudanese girl who presented with gradually progressive bilateral breast enlargement and accelerated growth since the age of 6 months. The family had sought medical advice several times in numerous health facilities without much gain. Investigations showed pubertal luteinizing hormone levels, high estradiol E2, and dehydroepiandrosterone sulfate, with normal early morning cortisol level. Abdominal ultrasound revealed a right-sided hypoechoic suprarenal mass. Abdominal computed tomography scan showed a right adrenal mass. The diagnosis of feminizing adrenal neoplasm was confirmed and right adrenalectomy was done. Histopathological examination of the resected adrenal gland showed adrenocortical adenoma. The patient was started on gonadotrophin-releasing hormone agonist for secondary central precocious puberty. Conclusion: Adrenocortical tumors, though rare in pediatrics, are a documented cause of precocious puberty; biochemical and imaging screening protocol should be adopted for patients with precocious puberty, even in a resource-limited setting, for early detection and treatment.